Crossmark

Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets

Crossref DOI link: https://doi.org/10.1186/s12920-019-0477-8

Published Online: 2019-02-08

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nava, Miguel

Dutta, Pranabananda

Zemke, Nathan R.

Farias-Eisner, Robin

Vadgama, Jaydutt V.

Wu, Yanyuan
Funding

Funding for this research was provided by:

National Institute on Minority Health and Health Disparities (U54MD007598, 5S21MD 000103)

National Cancer Institute (1U54CA14393)
License Information

Text and Data Mining valid from 2019-02-08

Version of Record valid from 2019-02-08
More Information

Article History

Received: 29 March 2018

Accepted: 29 January 2019

First Online: 8 February 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below